课题基金 / 基金详情

项目摘要

项目成果

CHYI S HSIEH的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):结肠耐受性丧失是一个重要的临床问题,因为它被认为会导致炎症性肠病。T细胞产生IL-10在维持结肠耐受中起重要作用。然而,目前尚不清楚IL-10是由T细胞对可能来自细菌的特定抗原做出反应产生的,还是通过细胞因子等非抗原特异性刺激在结肠T细胞上表达。这项建议的目的是通过在固定的TCR转基因小鼠中对TRAV14 TCRA谱系进行测序,来解决抗原特异性在选择结肠中的TR1和IL-10+调节性T(Treg)细胞方面是否重要。如果我们的假设是正确的,我们将观察到IL-10+亚群利用一组独特的TCR,这可能有助于建立TR1或IL-10+Treg细胞发育的TCR转基因模型。使用TCR测序数据,我们将选择常见的TR1和IL-10+Treg TCR来确定它们是否识别细菌,以及它们是否促进胸腺或外周T细胞的发育。TCR可重复性地导致外周TR1和IL-10+Treg细胞的发育,然后可用于建立TCR转基因模型,以研究T细胞中IL-10的调节。因此,这些研究将增加我们对产生IL-10的T细胞亚群的理解,这可能有助于开发治疗人类疾病的新疗法。
英文摘要
DESCRIPTION (provided by applicant): Loss of colonic tolerance is a significant clinical problem, as it is thought to result in inflammatory bowel disease. The production of IL-10 by T cells plays an important role in maintaining colonic tolerance. However, it is unclear whether IL-10 is produced by T cells responding to specific antigens potentially derived from bacteria, or is expressed on colonic T cells via non-antigen specific stimuli such as cytokines. The goal of this proposal is to address whether antigen specificity is important in selecting Tr1 and IL-10+ regulatory T (Treg) cells in the colon by sequencing the TRAV14 TCRa repertoire in fixed TCR¿ transgenic mice. If our hypothesis is correct, we will observe that the IL-10+ subsets utilize a unique set of TCRs, which may be useful for the generation of TCR transgenic models of Tr1 or IL-10+ Treg cell development. Using the TCR sequencing data, we will select common Tr1 and IL-10+ Treg TCRs to determine whether they recognize bacteria, and whether they facilitate thymic or peripheral T cell development. TCRs which reproducibly result in peripheral Tr1 and IL-10+ Treg cell development can then be used to generate TCR transgenic models to study IL-10 regulation in T cells. Thus, these studies will increase our understanding regarding how the IL-10 producing T cell subset is generated, which may be useful for developing novel therapies for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CAR-T cell treatment of CNS Autoimmunity
  • 批准号:
    10641913
  • 项目类别:
  • 资助金额:
    $68.34万
  • 财政年份:
    2022
  • 负责人:
    CHYI S HSIEH
  • 依托单位:
CAR-T cell treatment of CNS Autoimmunity
  • 批准号:
    10539779
  • 项目类别:
  • 资助金额:
    $67.19万
  • 财政年份:
    2022
  • 负责人:
    CHYI S HSIEH
  • 依托单位:
B cell-targeted CAR-T treatment of CNS Autoimmunity
  • 批准号:
    10514950
  • 项目类别:
  • 资助金额:
    $23.63万
  • 财政年份:
    2022
  • 负责人:
    CHYI S HSIEH
  • 依托单位:
Immune interactions with commensal microbes in early life
  • 批准号:
    10567936
  • 项目类别:
  • 资助金额:
    $71.52万
  • 财政年份:
    2022
  • 负责人:
    CHYI S HSIEH
  • 依托单位:
海外基金